These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9884283)

  • 1. Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching.
    Bryan CF; Baier KA; Nelson PW; Luger AM; Martinez J; Pierce GE; Ross G; Shield CF; Warady BA; Aeder MI; Helling TS; Muruve N
    Transplantation; 1998 Dec; 66(12):1827-32. PubMed ID: 9884283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved graft survival in cadaveric renal retransplantation by flow crossmatching.
    Nelson PW; Eschliman P; Shield CF; Aeder MI; Luger AM; Pierce GE; Bryan CF
    Arch Surg; 1996 Jun; 131(6):599-603. PubMed ID: 8645065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The flow cytometric crossmatch and early renal transplant loss.
    Mahoney RJ; Ault KA; Given SR; Adams RJ; Breggia AC; Paris PA; Palomaki GE; Hitchcox SA; White BW; Himmelfarb J
    Transplantation; 1990 Mar; 49(3):527-35. PubMed ID: 2138366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of high- and low-risk second kidney grafts.
    Mahoney RJ; Norman DJ; Colombe BW; Garovoy MR; Leeber DA
    Transplantation; 1996 May; 61(9):1349-55. PubMed ID: 8629295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigens.
    Bryan CF; Shield CF; Pierce GE; Warady BA; Aeder MI; Martinez J; Luger AM; Nelson PW; Ross G; Muruve N; Mitchell SI
    Clin Transplant; 2000 Feb; 14(1):79-84. PubMed ID: 10693641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal graft survival is not influenced by a positive flow B-cell crossmatch.
    Bryan CF; Wakefield M; Reese JC; Shield CF; Warady BA; Winklhofer FT; Murillo D
    Clin Transplant; 2007; 21(1):72-9. PubMed ID: 17302594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype.
    Bryan CF; Martinez J; Muruve N; Nelson PW; Pierce GE; Ross G; Shield CF; Warady BA; Aeder MI; Harrell KM; Helling TS; Luger AM
    Clin Transplant; 2001; 15 Suppl 6():28-35. PubMed ID: 11903383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.
    Karpinski M; Rush D; Jeffery J; Exner M; Regele H; Dancea S; Pochinco D; Birk P; Nickerson P
    J Am Soc Nephrol; 2001 Dec; 12(12):2807-2814. PubMed ID: 11729251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired renal graft survival after a positive B-cell flow-cytometry crossmatch.
    Bittencourt MC; Rebibou JM; Saint-Hillier Y; Chabod J; Dupont I; Chalopin JM; Herve P; Tiberghien P
    Nephrol Dial Transplant; 1998 Aug; 13(8):2059-64. PubMed ID: 9719165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
    Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
    Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.
    Kerman RH; Susskind B; Buyse I; Pryzbylowski P; Ruth J; Warnell S; Gruber SA; Katz S; Van Buren CT; Kahan BD
    Transplantation; 1999 Dec; 68(12):1855-8. PubMed ID: 10628764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent improvements in cadaver-donor kidney retransplantation.
    Mitsuishi Y; Cecka JM
    Clin Transpl; 1991; ():281-91. PubMed ID: 1820123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Heydari A; Kahan BD
    Transplantation; 1991 Feb; 51(2):316-20. PubMed ID: 1994522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants.
    O'Rourke RW; Osorio RW; Freise CE; Lou CD; Garovoy MR; Bacchetti P; Ascher NL; Melzer JS; Roberts JP; Stock PG
    Clin Transplant; 2000 Apr; 14(2):167-73. PubMed ID: 10770424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry beads rather than the antihuman globulin method should be used to detect HLA Class I IgG antibody (PRA) in cadaveric renal regraft candidates.
    Bryan CF; McDonald SB; Baier KA; Luger AM; Aeder MI; Murillo D; Muruve NA; Nelson PW; Shield CF; Warady BA
    Clin Transplant; 2002; 16 Suppl 7():15-23. PubMed ID: 12372039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated HLA mismatches and second renal graft survival in centers of the South-Eastern Organ Procurement Foundation.
    Heise ER; Thacker LR; MacQueen JM; Peters TG
    Clin Transplant; 1996 Dec; 10(6 Pt 2):579-85. PubMed ID: 8996746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients.
    Kerman RH; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Gerolami K; Kahan BD
    Transplantation; 1990 Jan; 49(1):52-6. PubMed ID: 2301027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
    Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
    Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.